This record was last updated March 14, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate the efficacy and safety of Praga formulation in the treatment of neuropathic pain.
Protocol Amendment History
4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-12-11; most recent amendment 2025-03-12.
Status change: Not Yet Recruiting → Recruiting2024-02-15